Skip to content
Tech News
← Back to articles

AI Can Now Design Functional Viruses. Should We Worry?

read original more articles
Why This Matters

The ability of AI to design functional viruses marks a significant breakthrough in biotechnology, enabling rapid development of targeted therapies such as bespoke phages to combat antibiotic-resistant bacteria. However, this technological advancement also raises serious biosecurity concerns, as the same tools could be misused to create harmful biological agents. This dual potential underscores the need for careful regulation and ethical considerations in the deployment of AI-driven biological design.

Key Takeaways

Sixteen viruses is not a large number. But the 16 bacteria-infecting viruses described on 6 August in Science were no ordinary specimens.

They were not fished out of a sewage outflow or dug up from a soil sample, which is where such things normally come from. They were written by a genomic language model trained on vast troves of DNA sequences. Researchers at Stanford University designed the small viruses from scratch, producing the first complete, functional genomes ever generated by AI.

And they worked. Delivered together as a cocktail, the designer viruses—known as bacteriophages, or phages—infected E. coli strains that had already evolved resistance to the natural virus they were modeled on, something a comparable mix of natural phages could not do.

The advance offers a glimpse of a future in which bespoke phage therapies are made to order to combat bacterial infections that antibiotics can no longer touch.

Phage therapies have been used to treat infectious diseases for more than a century, but the field has struggled with a combination of biological and commercial hurdles: Individual phages often kill only a narrow range of bacteria, resistance can evolve quickly, and naturally occurring phages can be difficult to patent.

AI-designed phages offer a way around some of those limitations—and Brian Hie, the Stanford computational biologist who led the new study, says collaborators have already begun asking to use their model to create phages capable of killing disease-causing bacteria, rather than targeting a laboratory strain of E. coli.

But the same AI methods also lower the technical barrier to building other kinds of biological agents on demand, including viruses with the potential to cause disease, sharpening a long-standing worry that systems developed for medicine and biotechnology could be turned, without much modification, into biological weapons.

“The question is no longer whether generative viral genome design will exist,” a pair of biosecurity experts at the Johns Hopkins Center for Health Security wrote in an accompanying commentary. “It is whether society can build oversight that allows its benefits to unfold while preventing it from enabling serious harm.”

How the Phages Were Made

Inside the phrase “designed from scratch” sits a long engineering pipeline.

... continue reading